VEGFA and neoplasm: Initial solutions aim to destroy the tumour blood vessels through anti‐angiogenic therapies that starve the tumours of oxygen and nutrients, primarily by targeting pro‐angiogenesis factors such as VEGF and their downstream pathways.36